Navigation Links
New way to make malaria medicine also first step in finding new antibiotics
Date:9/26/2008

University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive.

Metcalf set out to understand how this compound, one of a group known as phosphonates, is made in nature by bacteria. He was interested in that process partly because some phosphonates have antibiotic properties. Recently, Metcalf and his lab successfully identified and sequenced the genes and identified the processes by which bacteria make this particular phosphonate compound (FR900098).

His results are reported in the August 25 issue of Chemistry & Biology.

Although the compound has already been chemically synthesized, that is a costly process. By knowing how this phosphonate is biosynthesized, it can now be inexpensively mass-produced by harnessing the cellular machinery of bacteria.

"Malaria is a problem in Third World countries that can least afford expensive medicines, and many antibiotics are expensive," Metcalf said.

Efforts are already underway by Metcalf's colleague, chemical engineering professor Huimin Zhao, to engineer E. coli strains to overproduce FR900098, which can then be harvested for medicine.

In addition, says Metcalf, knowing the genes and understanding the pathway that bacteria use to make this antimalarial means the genes can be manipulated to make the compound even more effective against the malaria parasite while remaining harmless to people.

This effort to help treat malaria is just one facet of a major undertaking to find new antibiotics. Last year Metcalf and his colleagues at the U. of I.'s Institute for Genomic Biology, chemistry professor Wilfred van der Donk, Zhao, chemistry professor Neil Kelleher, and biochemistry professor Satish Nair, received a $7.3 million grant from the National Institutes of Health to investigate just this. Jo Ha
'/>"/>

Contact: Melissa Edwards
mme@illinois.edu
217-333-0873
University of Illinois at Urbana-Champaign
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. NTDs burden in Latin America and the Caribbean may exceed that of HIV/AIDS, TB and malaria
2. Best way to treat malaria: Avoid using same drug for everyone, scientists say
3. Johns Hopkins scientists discover what drives the development of a fatal form of malaria
4. Research exposes new target for malaria drugs
5. Scientists demonstrate feasibility of preventing malaria parasite from becoming sexually mature
6. Netting mosquitoes to prevent malaria
7. Monkey malaria widespread in humans and potentially fatal
8. CWRU School of Medicine has evidence vaccine against malaria will reduce disease
9. Study of malaria parasite in patient blood finds distinct physiological states
10. Bug-Zapper: A dose of radiation may help knock out malaria
11. MSU researcher helps develop computer game for Ugandan children recovering from cerebral malaria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New way to make malaria medicine also first step in finding new antibiotics
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
(Date:7/7/2015)... MOUNTAIN VIEW, Calif. , July 7, 2015 ... mobile biometrics market, Frost & Sullivan recognizes Credence ... & Sullivan Entrepreneurial Company of the Year ... product suite to aid in its mission of ... and under-recognized populations globally. As Credence ID was ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... scleroderma has slowed Tracy Zinn but it has not stopped ... accommodating employer, Zinn is now in her 13th year as ... But, many with the incapacitating disease are not as fortunate. ... people with systemic scleroderma, also known as systemic sclerosis, is ...
... 2011 DigitalPersona, Inc. , a global provider ... Pizza Hut™ franchisee Rage, Inc. has rolled out ... locations throughout the east coast in South Carolina, North ... By deploying fingerprint biometrics as a part of their ...
... 2001--Eating nuts every day could help control Type 2 ... from St. Michael,s Hospital and the University of Toronto. ... Diabetes Care , a team of researchers led ... Nutritional Sciences; St. Michael,s Hospital Risk Factor Modification Centre) ...
Cached Biology News:Scleroderma study identifies roadblocks to employment 2Scleroderma study identifies roadblocks to employment 3Pizza Hut Franchisee Saves Dough by Slicing Payroll Fraud and Leavening Store Revenue with Digital Persona Fingerprint Biometrics 2A 'nutty' solution to type 2 diabetes management 2
(Date:7/29/2015)... PARIS , July 30, 2015 ... leader, reports results for the second quarter of ... the group,s results and its performance in different ... transcript:  http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire ... - Q2 results - Performance drivers ...
(Date:7/29/2015)... Japan (Q2 2015: +14% CER / 20% of sales) ... in China , as well as solid contributions from Korea, ... Europe / Middle East / ... in Germany , Turkey and the ... 49% of sales) grew 11%, excluding U.S. HPV sales, on demand across all ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... manufacturer and supplier, announces the launch of their 2nd generation cell therapy POD® ... current miniPOD CT, but it also represents a new POD® design. , ...
(Date:7/29/2015)... NEW YORK , July 29, 2015 /PRNewswire/ ... neuropathology testing, announces increased partnerships with VA and ... offers Epidermal Nerve Fiber Density (ENFD) and Sweat ... of small fiber neuropathy ( https://therapath.com/skin ). ... Epidermal Nerve Fiber Density (ENFD) on punch skin ...
Breaking Biology Technology:QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3Neuropathology services for VA and Military health systems 2
... Corporation (OTC Bulletin Board: MFLU) announced today that the ... Monday, November 2, 2009, after the closing of the ... ) , Michael C. Ferrara, President and Chief ... Finance and Chief Accounting Officer, will host a conference ...
... -- In response to requests from clients, Schulman ... , The Schulman Canadian Board,s first official meeting is ... are conducted in both the U.S. and Canada, Canadian and ... to maintain consistency. , "Our clients have asked us to ...
... The Board of Directors of Biomoda, Inc. (OTC Bulletin ... cancer detection medical diagnostics company, has elected Maria Zannes ... the Biomoda Board May 1, 2008. , "Maria,s extraordinary ... perfect individual to safeguard our commitment to good corporate ...
Cached Biology Technology:Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2, 2009 2Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2, 2009 3Schulman Associates IRB Establishes an Institutional Review Board in Canada 2Biomoda Board of Directors Names New Corporate Secretary 2
Kit contains: Bio-Rad Amplification Reagent, 2x Amplification Diluent, Streptavidin-HRP, Blocking Reagent, and Phosphate Buffered Saline....
These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
Intestinal Epithelium Differentiation Environment...
Hepatocyte Differentiation Environment...
Biology Products: